Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL31690657 | 1.00 | ALDH1A1 (0.48) | ALDH1A1MAPTHPGDGMNNLMNA | |
| Ammonia Solution, Strong SCHEMBL28559423 | 0.97 | ALDH1A1 (0.46) | ALDH1A1MAPTHPGDGMNNLMNA | |
| SCHEMBL31283176 | 0.97 | ALDH1A1 (0.46) | ALDH1A1MAPTHPGDGMNNLMNA | |
| SCHEMBL221278 | 0.97 | — | — | |
| Potassium SCHEMBL7562143 | 0.95 | ALDH1A1 (0.43) | ALDH1A1MAPTHPGDGMNNLMNA | |
| SCHEMBL27573998 | 0.95 | ALDH1A1 (0.43) | ALDH1A1MAPTHPGDGMNNLMNA | |
| SCHEMBL28821686 | 0.95 | ALDH1A1 (0.43) | ALDH1A1MAPTHPGDGMNNLMNA | |
| SCHEMBL2237010 | 0.95 | ALDH1A1 (0.43) | ALDH1A1MAPTHPGDGMNNLMNA | |
| SCHEMBL27470249 | 0.95 | ALDH1A1 (0.43) | ALDH1A1MAPTHPGDGMNNLMNA | |
| SCHEMBL27609156 | 0.92 | ALDH1A1 (0.42) | ALDH1A1MAPTHPGDGMNNLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 628 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540162-B2 | Preparation of functional homocysteine residues in polypeptides and peptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-03 | — | — | US | claimed |
| EP-4626866-A1 | NOVEL TRILACICLIB INTERMEDIATES, METHOD OF PREPARATION AND USE THEREOF | Assia Chemical Industries Ltd. (IL) | 2025-10-08 | — | — | EP | claimed |
| EP-4095097-B1 | METAL-ADSORBING COMPOSITE MATERIAL BASED ON MAGNETIC GRAPHENE OXIDE AND METHOD FOR OBTAINING SAME | UNIV MALAGA (ES) | 2025-10-01 | — | — | EP | claimed |
| EP-4568984-A1 | PROCESS FOR MANUFACTURING AN ANTIBIOTIC MACROCYCLIC PEPTIDE | F. Hoffmann-La Roche AG (CH) | 2025-06-18 | — | — | EP | claimed |
| US-12331239-B2 | Composition and process for selectively etching a layer comprising an aluminium compound in the presence of layers of low-k materials, copper and/or cobalt | BASF SE (DE) | 2025-06-17 | — | — | US | claimed |
| WO-2024116069-A1 | NOVEL TRILACICLIB INTERMEDIATES, METHOD OF PREPARATION AND USE THEREOF | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2024-06-06 | — | — | WO | claimed |
| US-20240093089-A1 | COMPOSITION AND PROCESS FOR SELECTIVELY ETCHING A LAYER COMPRISING AN ALUMINIUM COMPOUND IN THE PRESENCE OF LAYERS OF LOW-K MATERIALS, COPPER AND/OR COBALT | BASF SE (DE) | 2024-03-21 | — | — | US | claimed |
| US-20240092833-A1 | PREPARATION OF FUNCTIONAL HOMOCYSTEINE RESIDUES IN POLYPEPTIDES AND PEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-03-21 | — | — | US | claimed |
| WO-2024033278-A1 | PROCESS FOR MANUFACTURING AN ANTIBIOTIC MACROCYCLIC PEPTIDE | F. HOFFMANN-LA ROCHE AG (CH) | 2024-02-15 | — | — | WO | claimed |
| WO-2023101457-A1 | COMPOSITION FOR PREVENTING OR TREATING BILIARY TRACT CANCER | 연세대학교 산학협력단 | 2023-06-08 | — | — | WO | claimed |
| US-6224785-B1 | CLEANING COMPOUNDS FOR POST PLASMA ETCHING AND ASHING | ADVANCED TECHNOLOGY MATERIALS, INC. | 2001-05-01 | — | — | US | claimed |
| US-6211126-B1 | Formulations including a 1, 3-dicarbonyl compound chelating agent for stripping residues from semiconductor substrates | ADVANCED TECHNOLOGY MATERIALS, INC. | 2001-04-03 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| WO-1998030667-A1 | SEMICONDUCTOR WAFER CLEANING COMPOSITION AND METHOD WITH AQUEOUS AMMONIUM FLUORIDE AND AMINE | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1998-07-16 | — | — | WO | claimed |
| US-5567619-A | PRECIPITATION, FILTRATION, COLORIMETRIC ANALYSIS | HYBRIVET SYSTEMS, INC. (US) | 1996-10-22 | — | — | US | claimed |
| EP-0506132-B1 | Method for removal of mercury in exhaust gas | ORIENTAL TECHNICAL RESEARCH IN (JP) | 1996-02-14 | — | — | EP | claimed |
| US-5416028-A | Process for testing for substances in liquids | HYBRIVET SYSTEMS, INC. (US) | 1995-05-16 | — | — | US | claimed |
| WO-1995005598-A1 | PROCESS AND APPARATUS FOR TESTING FOR SUBSTANCES IN LIQUIDS | HYBRIVET SYSTEMS, INC. (US) | 1995-02-23 | — | — | WO | claimed |
| US-4942024-A | DISSOLVING IN HYDROFLUORIC ACID OR OXALIC ACID, ADJUSTING THE PH WITH AMMONIUM PYRROLIDINEDITHIOCARBAMATE, PRECIPITATION | CENTRAL GLASS COMPANY, LIMITED (JP) | 1990-07-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240093089-A1 | COMPOSITION AND PROCESS FOR SELECTIVELY ETCHING A LAYER COMPRISING AN ALUMINIUM COMPOUND IN THE PRESENCE OF LAYERS OF LOW-K MATERIALS, COPPER AND/OR COBALT | STK11, CRKL, STK10 | ALDH1A1 3964/4885MAPT 1392/4885HPGD 4752/4885 |
| US-12540162-B2 | Preparation of functional homocysteine residues in polypeptides and peptides | PTMS, AHCY, BHMT2 | ALDH1A1 3178/4885MAPT 2741/4885HPGD 2879/4885 |
| US-12331239-B2 | Composition and process for selectively etching a layer comprising an aluminium compound in the presence of layers of low-k materials, copper and/or cobalt | STK11, CRKL, STK10 | ALDH1A1 3964/4885MAPT 1392/4885HPGD 4752/4885 |
| US-20240092833-A1 | PREPARATION OF FUNCTIONAL HOMOCYSTEINE RESIDUES IN POLYPEPTIDES AND PEPTIDES | BHMT2, BHMT, PTMS | ALDH1A1 4389/4885MAPT 4077/4885HPGD 1761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.